IRCT20191208045651N1 IRCT 2019-12-23 Iran University of Medical Sciences Comparison of Insulin Glargine and Detemir on Hormone Factors Affecting Appetite in Patients with Type 1 Diabetes Comparison of Insulin Glargine and Detemir on Hormone Factors Affecting Appetite in Patients with Type 1 Diabetes 2019-04-30 anticipated 41 Complete https://irct.ir/trial/44164 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: 41 children with new case of diabetes type 1 assigned with simple randomization, according to the table of random number and individual randomization unit. 21 children in the first intervention group (insulin glargine) and 20 (insulin Detemir) neonates in the second intervention group were selected. In this study, do not allocation concealment. 3 Type 1 Diabetes. Intervention 1: Intervention group 1: Includes new cases of type 1 diabetes that hospitalized. In this group, samples (n=21) received insulin Glargine for 3 months. Insulin Glargine was given to the patients once a day, subcutaneous injection and base on of 30-50% of the patient's daily requirement (based on age and clinical response). Intervention 2: Intervention group 2: Includes new cases of type 1 diabetes that hospitalized. In this group, samples (n=2خ) received insulin Detemir for 3 months. Insulin Detemir was given to the patients twice a day, subcutaneous injection and base on of 30-50% of the patient's daily requirement (based on age and clinical response). Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information